- Home
- ICMB vs SCNX Comparison
ICMB vs SCNX Comparison
Compare ICMB & SCNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ICMB | SCNX |
|---|---|---|
| Founded | 2012 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Other Pharmaceuticals |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.2M | 16.2M |
| IPO Year | 2013 | 2019 |
Fundamental Metrics
Financial Performance| Metric | ICMB | SCNX |
|---|---|---|
| Price | $0.87 | $0.34 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $1.50 |
| AVG Volume (30 Days) | 29.8K | ★ 361.9K |
| Earning Date | 05-13-2026 | 05-13-2026 |
| Dividend Yield | ★ 21.74% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $3,831,778.00 |
| Revenue This Year | $7.43 | $1,097.38 |
| Revenue Next Year | N/A | $239.80 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 30.72 |
| 52 Week Low | $0.73 | $0.24 |
| 52 Week High | $3.12 | $2.60 |
Technical Indicators
Market Signals| Indicator | ICMB | SCNX |
|---|---|---|
| Relative Strength Index (RSI) | 53.80 | 35.73 |
| Support Level | $0.86 | $0.30 |
| Resistance Level | $0.89 | $0.43 |
| Average True Range (ATR) | 0.03 | 0.03 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 65.79 | 6.53 |
Price Performance
Historical ComparisonAbout ICMB Investcorp Credit Management BDC Inc.
Investcorp Credit Management BDC Inc is an externally managed, non-diversified closed-end management investment firm that has elected to be regulated as a business development company (BDC). The investment objective of the company is to maximize total return to stockholders in the form of current income and capital appreciation by investing in debt and related equity of privately held lower middle-market companies. The company principally invests in the debt of middle-market companies, which it defines as those companies that have an enterprise value.
About SCNX Scienture Holdings Inc.
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on the commercialization and development of products for the treatment of cardiovascular (CVS) and Central Nervous System (CNS) diseases. Scienture LLC launched its first commercial product for hypertension and is in the process of commercializing its second product for the treatment of opioid overdose. Its development pipeline consists of a broad range of novel product candidates including new potential treatments for migraine, thrombosis, pain and other related disorders.